Commentary

Who among us has not asked a patient to keep track of a mole?


 

References

Whether or not it leads to an app that automatically diagnoses melanoma from patient mole selfies, Mole Mapper has value. Any tool that empowers patients to be actively involved in their care and to meticulously monitor their moles will surely help us in keeping them safe.

Dr. Benabio is a partner physician in the department of dermatology of the Southern California Permanente Group in San Diego, and a volunteer clinical assistant professor at the University of California, San Diego. Dr. Benabio is @dermdoc on Twitter. He has no conflicts relating to the topic of this column.

Pages

Recommended Reading

FDA proposes ban on indoor tanning for minors
MDedge Hematology and Oncology
FDA approves pembrolizumab as first-line advanced melanoma therapy
MDedge Hematology and Oncology
Cancer prevention field riding high into the new year
MDedge Hematology and Oncology
EADV: Vismodegib treatment breaks don’t hurt efficacy
MDedge Hematology and Oncology
Sirolimus reduced posttransplant skin cancer risk
MDedge Hematology and Oncology
Encouraging results for MMS in digital melanoma cases
MDedge Hematology and Oncology
MAPK inhibitor combo offers prolonged survival from BRAF+ advanced melanoma
MDedge Hematology and Oncology
Anorectal melanoma rates rose significantly in 20-year analysis
MDedge Hematology and Oncology
Organ transplant recipients face increased risk of BCC
MDedge Hematology and Oncology
Dabrafenib may be useful in patients who discontinue vemurafenib
MDedge Hematology and Oncology